“Nonparametric analysis of covariance for comparing change in randomized studies with baseline values subject to error.”, Biometrics, vol. 47, no. 2, pp. 523-33, 1991.
, “Antiulcer agents. 4-substituted 2-guanidinothiazoles: reversible, competitive, and selective inhibitors of gastric H+,K(+)-ATPase.”, J Med Chem, vol. 33, no. 2, pp. 543-52, 1990.
, “Challenges of HIV vaccine development.”, Stat Med, vol. 9, no. 12, pp. 1425-31; discussion 1433-7, 1990.
, “Hematocrit values in the CAPD/CCPD population: a report of the National CAPD Registry.”, Perit Dial Int, vol. 10, no. 4, pp. 275-8, 1990.
, “Mesothelioma in Cyprus.”, IARC Sci Publ, no. 90, pp. 411-9, 1989.
, “The Mid-Atlantic Oncology Program's comparison of two data collection methods.”, Control Clin Trials, vol. 10, no. 3, pp. 282-9, 1989.
, “Rilmenidine and vigilance. Review of clinical studies.”, Am J Med, vol. 87, no. 3C, p. 67S-72S, 1989.
, “Timing and characteristics of multiple peritonitis episodes: a report of the National CAPD Registry.”, Am J Kidney Dis, vol. 14, no. 1, pp. 44-9, 1989.
, “The 1987 USA National CAPD Registry report.”, ASAIO Trans, vol. 34, no. 2, pp. 150-6, 1988.
, “Current concepts. Continuous ambulatory peritoneal dialysis.”, N Engl J Med, vol. 318, no. 24, pp. 1595-600, 1988.
, “A survey of the NIH CAPD Registry population with end-stage renal disease attributed to diabetic nephropathy.”, J Diabet Complications, vol. 2, no. 4, pp. 227-32, 1988.
, “Comparison of unique leucovorin and 5-fluorouracil "escalating" and "maximum" dosage strategies.”, NCI Monogr, no. 5, pp. 179-84, 1987.
, “Current status and future directions of clinical trials in chronic lymphocytic leukemia.”, Oncology (Williston Park), vol. 1, no. 8, pp. 31-40, 44, 1987.
, “The effects of liver directed radiotherapy and chemotherapy on liver function tests and hematological parameters in patients with surgically resected colon cancer: findings from the Gastrointestinal Tumor Study Group.”, Am J Gastroenterol, vol. 82, no. 8, pp. 738-43, 1987.
, “Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer.”, N Engl J Med, vol. 317, no. 23, pp. 1433-8, 1987.
, “Community practice and cancer clinical trials: II. Detection of recurrences in rectal cancer.”, Hawaii Med J, vol. 45, no. 8, p. 261, 1986.
, “Community practice and cancer clinical trials: III. Value of platelet and differential counts.”, Hawaii Med J, vol. 45, no. 8, p. 262, 1986.
, “Importance of tumor pathology and morphology in patients with surgically resected colon cancer. Findings from the Gastrointestinal Tumor Study Group.”, Cancer, vol. 58, no. 6, pp. 1340-5, 1986.
, “Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effect.”, N Engl J Med, vol. 314, no. 2, pp. 119-20, 1986.
, “Perineal effects of postoperative treatment for adenocarcinoma of the rectum.”, Int J Radiat Oncol Biol Phys, vol. 12, no. 2, pp. 167-71, 1986.
, “Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience.”, Cancer, vol. 57, no. 9, pp. 1866-70, 1986.
, “Survival after postoperative combination treatment of rectal cancer.”, N Engl J Med, vol. 315, no. 20, pp. 1294-5, 1986.
, “Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum.”, Cancer, vol. 57, no. 6, pp. 1130-4, 1986.
, “Prostaglandin production by rat vaginal tissue, in vitro, in response to ethanol, a mild mucosal irritant.”, Toxicol Appl Pharmacol, vol. 78, no. 3, pp. 458-63, 1985.
, “Statistical aspects of intraperitoneal chemotherapy studies.”, Semin Oncol, vol. 12, no. 3 Suppl 4, pp. 121-3, 1985.
,